Archive for October 2019
Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia.
Favie L. M. A., Peeters-Scholte C. M. P. C. D., Bakker A., Tjabbes H., Egberts T. C. G., van Bel F., Rademaker C. M. A., Vis P., Groenendaal F. Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia. Pediatr. Res.: 2019. [Link to publication]
Read MoreExploration of efficacious alternative regorafenib regimens to manage hand − foot skin reaction
Grothey A., Hoefman S., Ruppert M., Vis P., Zisowsky J., Cutsem E., Dochy E.v. Fiala-buskies S., Cleton A., Ploeger B. Exploration of efficacious alternative regorafenib regimens to manage hand − foot skin reaction. ESMO, 2019.
Read MoreNonlinear mixed-effects model development and simulation using nlmixr and related R open source packages
Fidler M., Wilkins J.J., Hooijmaijers R., Post T.M., Schoemaker R,. Trame M.N., Xiong Y., Wang W.. Nonlinear mixed-effects model development and simulation using nlmixr and related R open source packages. CPT Pharmacometrics Syst Pharmacol: 621-633, 2019. [Link to publication]
Read More